dpp-4 inhibitors vs. glp-1 agonist PDF] Effects Of Analogues, And SGLT2 Inhibitors On The Renal System DPP-4 inhibitors and GLP-1RAs: cardiovascular

The well-established healthcare infrastructure and widespread access to advanced medications like Semaglutide and Tirzepatide facilitated rapid adoption

Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): A 56-week, double-blind, phase 3a, randomised trial

[DOI] [PMC free article] [PubMed] [Google Scholar] 615.Wang S.X., Xie Y., Zhou X., Sha W.W., Wang W.L., Han L.P

Furthermore, SGLT2-i interference with either generation or effect of ANG II at renal tissues site possibly plays a significant role in this setting

Peptide degradation in the gastrointestinal tract poses a significant challenge in the development of oral formulations of incretin analogues

Mol Metab 46:101090 Miyake T, Yoshida O, Matsuura B et al (2022) additional effect of luseogliflozin on semaglutide in nonalcoholic steatohepatitis complicated by type 2 diabetes mellitus: an open-label, randomized, parallel-group study